文献速递临床试验与 GCP流行病学与生物统计

远程神经认知评估的可行性:帕金森病合并阻塞性睡眠呼吸暂停患者临床试验在疫情期间的适应性调整——持续气道正压通气治疗对认知影响研究(COPE-PAP)

Feasibility of remote neurocognitive assessment: pandemic adaptations for a clinical trial, the Cognition and Obstructive Sleep Apnea in Parkinson's Disease, Effect of Positive Airway Pressure Therapy (COPE-PAP) study.
PubMed 文献 · Trials · 2021-12-11

该研究描述在COVID-19疫情期间,对参与随机对照试验的帕金森病合并阻塞性睡眠呼吸暂停患者,将3个月访视的神经认知测试由面对面改为电话施测的可行性。7例参与者完成远程测试,数据完整;与面对面对照组相比,远程组更年轻(60.6岁 vs 70.6岁)且病程更短(3.9年 vs 9.2年)。MoCA的组间重测差异为-0.69(95%CI -3.67, 2.29),MoCA一致性良好,特定神经认知测试一致性不一。结论认为电话施测MoCA及改良神经认知组合可行,但需更大样本进一步验证。

要点

  • 电话施测MoCA及改良神经认知组合在帕金森病合并OSA患者中可行,数据完整。
  • 远程组较面对面对照组更年轻(60.6岁 vs 70.6岁)、病程更短(3.9年 vs 9.2年)。
  • MoCA重测组间差异-0.69(95%CI -3.67, 2.29),MoCA一致性良好,特定测试一致性不一。

核心结论

  • 电话施测MoCA及改良神经认知组合在帕金森病合并阻塞性睡眠呼吸暂停患者中可行,进一步验证需要更大样本量。

研究设计与样本

  • 研究为随机对照试验(COPE-PAP)中的可行性分析,纳入MoCA评分≤27的帕金森病合并阻塞性睡眠呼吸暂停患者。
  • 因COVID-19疫情限制,3个月访视由面对面改为电话施测,兼容测试材料邮寄给参与者并于当日由快递取回。
  • 探索性分析比较对照组基线 vs 3个月结果(配对t检验),并用组内相关系数(ICC)评估一致性。

主要发现

  • 7例参与者被接触并同意在3个月随访时接受远程神经认知测试,远程测试数据完整。
  • 与面对面神经认知测试对照组相比,远程组更年轻(60.6岁 vs 70.6岁)且病程更短(3.9年 vs 9.2年)。
  • MoCA平均重测差异在面对面与远程对照组间相似,组间差异为-0.69(95%CI -3.67, 2.29)。
  • MoCA一致性良好,特定神经认知测试的一致性不一。

局限性

  • 进一步验证需要更大样本量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The COVID-19 pandemic poses challenges for timely outcome assessment in randomized clinical trials (RCT). Our aim was to describe our remote neurocognitive testing (NCT) protocol administered by telephone in patients with Parkinson's disease (PD) and obstructive sleep apnea (OSA). METHODS: We studied PD patients with OSA and Montreal Cognitive Assessment (MoCA) score ≤ 27 participating in a RCT assessing OSA treatment impact on cognition. Trial outcomes included change in MoCA and specific cognitive domains from baseline to 3 and 6 months. With COVID19 pandemic-related restrictions, 3-month visits were converted from in-person to telephone administration with materials mailed to participants for compatible tests and retrieved by courier the same day. In exploratory analyses, we compared baseline vs. 3-month results in the control arm, which were not expected to change significantly (test-re-test), using a paired t-test and assessed agreement with the intraclass correlation coefficient (ICC). RESULTS: Seven participants were approached and agreed to remote NCT at 3-month follow-up. Compared to the in-person NCT control arm group, they were younger (60.6 versus 70.6 years) and had a shorter disease course (3.9 versus 9.2 years). Remote NCT data were complete. The mean test-retest difference in MoCA was similar for in-person and remote NCT control-arm groups (between group difference - 0.69; 95%CI - 3.67, 2.29). Agreement was good for MOCA and varied for specific neurocognitive tests. CONCLUSION: Telephone administration of the MoCA and a modified neurocognitive battery is feasible in patients with PD and OSA. Further validation will require a larger sample size.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lajoie AC, Crane J, Robinson AR, et al. Feasibility of remote neurocognitive assessment: pandemic adaptations for a clinical trial, the Cognition and Obstructive Sleep Apnea in Parkinson's Disease, Effect of Positive Airway Pressure Therapy (COPE-PAP) study. Trials. 2021. PMID: 34895299. doi:10.1186/s13063-021-05879-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。